UK's BIA launches regenerative medicine group, holds talks with government

The UK's BioIndustry Association has launched an industry group for regenerative medicine companies at an event in London. The BIA RegenMed  Industry Group (RIG) is intended to provide "a coherent voice for this  developing community in the UK," the BIA stated.

The RIG aims to engage with a range of stakeholders about the emergence  of regenerative medicine as an industry, and its potential importance  for delivering new therapies to patients. It recognizes the diverse  nature of the regenerative medicine community which includes companies  developing therapies that replace or regenerate human cells, tissue or  organs. The group has been formed to highlight the issues facing the  future development of the sector.

Aisling Burnand, the BIA's chief executive said: "the BIA has championed  the needs and potential of this sector over the last few years. We are  delighted to bring together a group of companies that are developing  cutting edge technologies and products that will have the potential to  transform health care delivery for patients worldwide. We will continue  to raise awareness of this growing industry and engage with politicians,  investors and regulators on how regenerative medicine can deliver health  and economic benefits for the UK."